Middle East Pharmaceutical Industries Company: Business Overview, Financials & Competitive Analysis
Middle East Pharmaceutical Industries Company scores 6/10 on the AskCyborg Cyborg Score (Solid). Growth-oriented play on Saudi Arabia's healthcare expansion with proven manufacturing capabilities, though valuation multiples and market share trajectory require close monitoring. Avalon benefits from established manufacturing infrastructure, diversified product portfolio, and recent capital market access through IPO. However, as a newly listed entity in a competitive pharmaceutical.
What is Middle East Pharmaceutical Industries Company's industry? Middle East Pharmaceutical Industries Company (avalonpharmaceutical.com) operates in Pharmaceutical Manufacturing & Generic Medicines. AskCyborg classifies Middle East Pharmaceutical Industries Company under Pharmaceutical Manufacturing & Generic Medicines in its company registry.
Avalon Pharma develops, manufactures, markets, and distributes a range of pharmaceutical and generic medicines in Saudi Arabia and abroad through a diverse, high-quality product portfolio covering several therapeutic ...
Cyborg Score thesis
Growth-oriented play on Saudi Arabia's healthcare expansion with proven manufacturing capabilities, though valuation multiples...
Read the full analyst-debate transcript →Get the Latest Middle East Pharmaceutical Industries Company Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMiddle East Pharmaceutical Industries Company Overview
Pro stress-test →Avalon Pharma develops, manufactures, markets, and distributes a range of pharmaceutical and generic medicines in Saudi Arabia and abroad through a diverse, high-quality product portfolio covering several therapeutic categories. The company produces more than 250 products, falling under more than 70 brands. Recently listed on Tadawul (February 27, 2024), Avalon represents a significant entrant in the Saudi pharmaceutical sector with established manufacturing capabilities and geographic expansion.
Strategic Profile
Pro stress-test →The company operates three factories in Riyadh equipped with production and manufacturing lines for creams, cosmetics, liquid and solid medicines, and disinfectants. Avalon Pharma has a wholly owned subsidiary in the UK, Avalon Pharma UK Holdings Limited, which owns three subsidiaries, demonstrating international growth ambitions. The company leverages vertical integration across manufacturing and distribution to address regional healthcare needs in underserved therapeutic categories.
Competitive Landscape
Pro stress-test →Avalon Pharma competes in Saudi Arabia's pharma, biotech and life sciences sector alongside peers including Jamjoom Pharma (4015), SPIMACO (2070), and regional healthcare providers such as Mouwasat, Dallah Health, and Saudi German Health. As a generic medicine and OTC-focused player with manufacturing scale, Avalon differentiates through in-house production efficiency and regional distribution networks versus import-dependent competitors. Market consolidation and Vision 2030 localization initiatives favor integrated manufacturers.
Industry Context
Middle East Pharmaceutical Industries Company operates in Pharmaceutical Manufacturing & Generic Medicines.
Key facts
Founded: 1998 · Headquarters: Riyadh, Saudi Arabia · Employees: 501-1000 · Market cap: $438M